Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- Analyst Ratings
Upturn AI SWOT - About
AMED 
Amedisys Inc (AMED)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
06/13/2025: AMED (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Analysis of Past Performance
Type Stock | Historic Profit -1.34% | Avg. Invested days 50 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Star Rating | Upturn Advisory Performance  4.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 06/13/2025 |
Key Highlights
Company Size Mid-Cap Stock | Market Capitalization 3.19B USD | Price to earnings Ratio 35.85 | 1Y Target Price 97.38 |
Price to earnings Ratio 35.85 | 1Y Target Price 97.38 | ||
Volume (30-day avg) 363233 | Beta 0.94 | 52 Weeks Range 82.15 - 98.95 | Updated Date 06/15/2025 |
52 Weeks Range 82.15 - 98.95 | Updated Date 06/15/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) 2.71 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 3.79% | Operating Margin (TTM) 10.11% |
Management Effectiveness
Return on Assets (TTM) 6.36% | Return on Equity (TTM) 7.15% |
Valuation
Trailing PE 35.85 | Forward PE 21.19 | Enterprise Value 3355888028 | Price to Sales(TTM) 1.34 |
Enterprise Value 3355888028 | Price to Sales(TTM) 1.34 | ||
Enterprise Value to Revenue 1.42 | Enterprise Value to EBITDA 13.96 | Shares Outstanding 32819600 | Shares Floating 32175060 |
Shares Outstanding 32819600 | Shares Floating 32175060 | ||
Percent Insiders 1.96 | Percent Institutions 93.04 |
Analyst Ratings
Rating 2.91 | Target Price 96.17 | Buy 1 | Strong Buy - |
Buy 1 | Strong Buy - | ||
Hold 9 | Sell - | Strong Sell 1 | |
Strong Sell 1 |
Upturn AI SWOT
Amedisys Inc
Company Overview
History and Background
Amedisys Inc. was founded in 1982. Initially focused on providing hospice services, it expanded into home health and personal care. Through acquisitions and organic growth, it became a leading provider of home health, hospice, and personal care services. In 2023, UnitedHealth Group Incorporated (UHG) announced an agreement to acquire Amedisys.
Core Business Areas
- Home Health: Provides a range of medical services in patients' homes, including skilled nursing, therapy, and personal care. Focused on helping patients recover from illness, injury, or surgery.
- Hospice: Offers palliative care and support to patients with terminal illnesses and their families. Focuses on comfort, dignity, and quality of life.
- Personal Care: Provides assistance with activities of daily living, such as bathing, dressing, and meal preparation, to help individuals maintain independence in their homes.
Leadership and Structure
The CEO is Richard Ashworth (as of October 2023). The organizational structure includes executive leadership overseeing the various business segments and support functions.
Top Products and Market Share
Key Offerings
- Home Health Services: Offers skilled nursing, physical therapy, occupational therapy, speech therapy, and medical social services in the home. Competitors include LHC Group, Encompass Health, and Brookdale Senior Living. Market share is estimated, and varies by region and service type.
- Hospice Care: Provides comprehensive care for terminally ill patients, including medical, emotional, and spiritual support. Competitors include Kindred at Home (now Gentiva), and a network of local hospice organizations. Market share varies significantly by geographic area.
- Personal Care Services: Provides non-medical assistance with activities of daily living. Competitors include Comfort Keepers, Home Instead Senior Care, and Visiting Angels. Market share is fragmented and dependent on local operations.
Market Dynamics
Industry Overview
The home health and hospice industry is driven by an aging population, increasing prevalence of chronic diseases, and a shift towards value-based care. The industry is highly regulated and competitive.
Positioning
Amedisys is a large player in the fragmented home health and hospice market, known for its clinical expertise and technology-enabled care delivery. Its competitive advantages include a national footprint and a strong reputation.
Total Addressable Market (TAM)
The total addressable market for home health and hospice care in the US is estimated to be over $200 billion. Amedisys is positioned to capture a significant share through organic growth and acquisitions.
Upturn SWOT Analysis
Strengths
- Established brand reputation
- Large national footprint
- Comprehensive service offerings
- Strong clinical expertise
- Technology-enabled care delivery
Weaknesses
- High labor costs
- Regulatory compliance challenges
- Dependence on government reimbursement
- Potential for service quality issues
Opportunities
- Growing aging population
- Increasing prevalence of chronic diseases
- Shift towards value-based care
- Expansion into new markets
- Acquisitions of smaller providers
Threats
- Changes in government reimbursement policies
- Increased competition
- Rising labor costs
- Cybersecurity threats
- Economic downturn
Competitors and Market Share
Key Competitors
- LHCG
- ENVH
- GNTVA
Competitive Landscape
The home health and hospice market is highly competitive, with a mix of large national players and smaller regional providers. Amedisys competes on the basis of quality of care, service offerings, geographic coverage, and price.
Major Acquisitions
Contessa Health
- Year: 2021
- Acquisition Price (USD millions): 250
- Strategic Rationale: Expanded Amedisys' capabilities in hospital-at-home and high-acuity care.
Growth Trajectory and Initiatives
Historical Growth: Amedisys has grown through organic expansion and acquisitions. Revenue growth has been driven by increasing demand for home health and hospice services.
Future Projections: Future growth projections are subject to market conditions, regulatory changes, and the company's ability to execute its strategic plan. Analyst estimates should be consulted for specific projections.
Recent Initiatives: Recent initiatives may include investments in technology, expansion into new markets, and acquisitions of smaller providers.
Summary
Amedisys is a well-established player in the home health and hospice market with a strong brand and national footprint. The pending acquisition by UnitedHealth Group will likely reshape its future. The company faces challenges related to regulatory compliance, labor costs, and competition. Successful integration with UnitedHealth Group is crucial for future success.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company Filings (SEC)
- Industry Reports
- Analyst Estimates
Disclaimers:
This analysis is based on publicly available information and is for informational purposes only. It should not be considered financial advice. Market data is illustrative and may vary.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Amedisys Inc
Exchange NASDAQ | Headquaters Baton Rouge, LA, United States | ||
IPO Launch date 1994-08-17 | President, CEO & Director Mr. Richard M. Ashworth | ||
Sector Healthcare | Industry Medical Care Facilities | Full time employees 19000 | Website https://www.amedisys.com |
Full time employees 19000 | Website https://www.amedisys.com | ||
Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients. The Hospice segment offers services that is designed to provide comfort and support for those who are dealing with a terminal illness, including cancer, heart disease, pulmonary disease, or Alzheimer's. The High Acuity Care offers essential elements of inpatient hospital, skilled nursing facility care, and palliative care to patients in their homes. Amedisys, Inc. was incorporated in 1982 and is headquartered in Baton Rouge, Louisiana.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.